Literature DB >> 28458838

A surgical approach to the craniofacial defects of Opitz G/BBB syndrome.

John P Regan1, Karen Szymanski2, Silvio Podda2, Francesco Gargano2, Anthony Kopiecki3.   

Abstract

Opitz syndrome is a rare genetic disorder which has been well defined; however, the surgical treatment of the anomalies has not been codified. The objective is to review the literature and describe the surgical priorities in the treatment of Opitz syndrome. This report is unique in the fact that it describes a surgical approach to the treatment of the deformities. Better outcomes are achieved with preoperative analysis of the deformities and surgical planning. Simultaneous soft tissues and bony reconstruction with grafts can achieve long lasting results and decrease recurrence rates.

Entities:  

Year:  2017        PMID: 28458838      PMCID: PMC5400445          DOI: 10.1093/jscr/rjx032

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


INTRODUCTION

Opitz G/BBB Syndrome is a constellation of congenital deformities including laryngotracheoesophageal anomalies, developmental delays, genital defects as well as craniofacial defects. The syndrome receives its name from a combination of the names of the first families affected as well as the doctor who first recognized and described the pattern consistent with the syndrome [1, 2]. The syndrome is rare and manifested through two distinct inheritance patterns. It can be inherited through an X-linked arrangement, known as XLOS, or through an autosomal dominant pattern. In a small subset of patients, no recognizable inheritance pattern is appreciated [3, 4]. The incidence of XLOS is ~1 in 10 000–50 000 and affects males with females being carriers. It is likely that the incidence is higher due to lack of recognition leading to underdiagnosis. The abnormality responsible for this syndrome is a mutation in the MID1 gene which produces the midline-1 protein responsible for microtubule binding. The normal function of the protein allows for activation of key elements of the cytoskeleton as well as induction of cell migration. Therefore, mutations in this gene result in defects of mitosis through cell division and migration of cellular elements [5]. Autosomal dominant Opitz is part of larger syndrome referred to as 22q11.2 Deletion Syndrome. It is estimated to affect ~1 in 4000 individuals. The exact genes involved in clinical signs and symptoms of Opitz G/BBB syndrome is not known, while in others it is caused by a mutation involving the SPECC1L gene. It is important to note that the area of deletion is not typically seen in individuals with autosomal dominant Opitz syndrome or the 22q11.2 deletion syndrome. This gene is responsible for the production of cytospin-A which interacts with cytoskeletal elements and microtubule stabilization. This is important in cell migration of facial features. This is likely why individuals with this mutation have cleft lips and palates [1, 6–8]. The clinical manifestations of the syndromes typically present in similar manners independent from the inheritance pattern. Patients with laryngotracheoesophageal defects such as laryngotracheal diastema can present with recurrent respiratory infections, pneumonia, dysphagia and possibly require tracheostomy [3]. Developmental delays or intellectual disabilities occur in approximately half of the patients. They may also present with neuropsychiatric disorders such as delayed motor skills caused by agenesis of the corpus callosum and cerebellar vermis or symptoms consistent within the autism spectrum [9]. Approximately 85% of males affected with the disorder may present with genital deformities such as hypospadias, a bifid scrotum or cryptorchidism [1]. Other less common presenting deformities can be imperforate or ectopic anus and congenital heart defects such as ventricular septal defects [3]. Craniofacial defects will be manifested as ocular hypertelorism, prominent forehead and widow's peak, cleft lip and palate, broad nasal bridge, anteverted nares, encephalocele and bilateral low-set prominent ears. These defects may only be present in 50% of affected individuals and also vary between affected family members [3].

CASE REPORT

Our case is a 21-year-old male born with clinical manifestations consistent with Opitz G/BBB syndrome including severe bilateral cleft lip and palate, hypertelorism, low-set prominent ears and midfacial hypoplasia. His history was complicated with respiratory distress requiring tracheostomy at 8 months of age. He had also developed gastric volvulus requiring partial gastric resection and gastrostomy. In Fig. 1, the asymmetries at the upper lip, widened and short philtrum, bilateral widened and displaced alar base, poor nose tip projection and shortened columella are shown.
Figure 1:

Preoperative evaluation showing bilateral cleft lip and palate, hypertelorism, low-set prominent ears and midfacial hypoplasia.

Preoperative evaluation showing bilateral cleft lip and palate, hypertelorism, low-set prominent ears and midfacial hypoplasia. Functional evaluation of the nose revealed a positive Cottle maneuver for bilateral internal valve collapse, external valve collapse on forced inspiration, bilateral retracted and notched ala, shortened columella and poor tip projection. The patient was planned for a single staged procedure including an open rhinoplasty, complete lip revision and Keen approach to the midface. The surgical plan was devised to address each functional impairment of the craniofacial defects as shown in Fig. 2. The procedures were planned with the following sequence:
Figure 2:

Intraoperative findings with correction of cleft lip and rhinoplasty.

Bilateral internal nasal valve collapse with bilateral spreader grafts Bilateral external nasal valve collapse with bilateral batten grafts Bilateral retracted and notched ala with bilateral rim grafts Shortened columella with double V–Y flaps Poor tip projection with columellar strut Hypoplastic midface and pyriform rim with costocondral rib grafts Lip shortening and vermillion deficiency with dermal graft Intraoperative findings with correction of cleft lip and rhinoplasty. A 6-month follow-up was scheduled to review the restorative results. Surgical correction of the severe cleft lip, nasal deformities and midfacial hypoplasia showed significant improvement in symmetry and aesthetic result. Nasal airway function was optimal at both the internal and external nasal valves as evidenced by negative Cottle maneuver. The alar base was corrected to a symmetric position. The grafts maintained their structure and had little resorption. Bone grafts proved to provide adequate scaffolds at the pyriform rim. The patient has not undergone further revision.

DISCUSSION

A thorough search through the literature reveals that the majority of available data published on Opitz Syndrome only defined the clinical manifestations of the syndrome. There is little published data regarding the surgical management. In this patient, when creating the surgical plan, the elements that affected the choice of procedures were to first correct the functionally compromised collapsed nasal valves then to proceed with the structural defects. The use of simultaneous grafts can improve outcomes eliminating the necessity of multiple surgical interventions to obtain the same result. It shows that bone graft use at the pyriform rim can provide adequate scaffolding support to the ala position. Notably, performing the cleft rhinoplasty first prevented a ‘locking down’ effect of the reconstructed lip. This indicates the nose maintains proper projection and height during reconstruction of the lip as shown in Figs 3 and 4.
Figure 3:

Postoperative results.

Figure 4:

Side by side comparison of preoperative findings and postoperative results.

Postoperative results. Side by side comparison of preoperative findings and postoperative results. Our report highlights a functional and rational approach to correct the craniofacial deformities associated with Opitz G/BBB Syndrome. It provides an enhancement in anatomic function which can decrease diseases associated with defects. It also produces a considerable improvement is aesthetic outcomes.

CONFLICT OF INTEREST STATEMENT

None declared.

FUNDING

The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
  9 in total

1.  MID1 mutations in patients with X-linked Opitz G/BBB syndrome.

Authors:  Bianca Fontanella; Giorgio Russolillo; Germana Meroni
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

2.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

3.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

4.  The Opitz syndrome: a new designation for the clinically indistinguishable BBB and G syndromes.

Authors:  M Cappa; P Borrelli; R Marini; G Neri
Journal:  Am J Med Genet       Date:  1987-10

5.  Multidisciplinary management of Opitz G BBB syndrome.

Authors:  S Y Parashar; P J Anderson; T C Cox; N McLean; D J David
Journal:  Ann Plast Surg       Date:  2005-10       Impact factor: 1.539

6.  Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G/BBB syndrome.

Authors:  Paul Kruszka; Dong Li; Margaret H Harr; Nathan R Wilson; Daniel Swarr; Elizabeth M McCormick; Rosetta M Chiavacci; Mindy Li; Ariel F Martinez; Rachel A Hart; Donna M McDonald-McGinn; Matthew A Deardorff; Marni J Falk; Judith E Allanson; Cindy Hudson; John P Johnson; Irfan Saadi; Hakon Hakonarson; Maximilian Muenke; Elaine H Zackai
Journal:  J Med Genet       Date:  2014-11-20       Impact factor: 6.318

7.  Brain magnetic resonance imaging findings in the Opitz G/BBB syndrome: extension of the spectrum of midline brain anomalies.

Authors:  M R MacDonald; G B Schaefer; A H Olney; M Tamayo; J L Frías
Journal:  Am J Med Genet       Date:  1993-07-01

Review 8.  BBBG syndrome or Opitz syndrome: new family.

Authors:  A Verloes; M Le Merrer; M L Briard
Journal:  Am J Med Genet       Date:  1989-11

Review 9.  X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.

Authors:  Francesca De Falco; Silvia Cainarca; Grazia Andolfi; Rosa Ferrentino; Caterina Berti; German Rodríguez Criado; Olaf Rittinger; Nick Dennis; Sylvie Odent; Amit Rastogi; Jan Liebelt; David Chitayat; Robin Winter; Harindar Jawanda; Andrea Ballabio; Brunella Franco; Germana Meroni
Journal:  Am J Med Genet A       Date:  2003-07-15       Impact factor: 2.802

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.